Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241210349 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yan-Jun Zong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Deafness, Hearing Loss. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National key research and development program, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
The connexin gene family is the most prevalent gene that contributes to hearing loss. Connexins 26 and 30, encoded by GJB2 and GJB6, respectively, are the most abundantly expressed connexins in the inner ear. Connexin 43, which is encoded by GJA1, appears to be widely expressed in various organs, including the heart, skin, the brain, and the inner ear. The mutations that arise in GJB2, GJB6, and GJA1 can all result in comprehensive or non-comprehensive genetic deafness in newborns. As it is predicted that connexins include at least 20 isoforms in humans, the biosynthesis, structural composition, and degradation of connexins must be precisely regulated so that the gap junctions can properly operate. Certain mutations result in connexins possessing a faulty subcellular localization, failing to transport to the cell membrane and preventing gap junction formation, ultimately leading to connexin dysfunction and hearing loss. In this review, we provide a discussion of the transport models for connexin 43, connexins 30 and 26, mutations affecting trafficking pathways of these connexins, the existing controversies in the trafficking pathways of connexins, and the molecules involved in connexin trafficking and their functions. This review can contribute to a new way of understanding the etiological principles of connexin mutations and finding therapeutic strategies for hereditary deafness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan 430022, China.
ORCID-Profile: Yu Sun
Förderung
- National key research and development program
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Wuhan Knowledge Innovation Special Basic Research Project
Zitieren
APA
Zong, Y. J., Liu, X. Z., Tu, L., & Sun, Y. (2023). Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210349
Vancouver
Zong YJ, Liu XZ, Tu L, Sun Y. Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210349
BibTeX
@article{Zong2023,
author = {Zong, Yan-Jun and Liu, Xiao-Zhou and Tu, Lei and Sun, Yu},
title = {Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241210349}
}
EUVIMED